BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,975,286
- Total 13F shares
- 177,577,894
- Share change
- +2,590,792
- Total reported value
- $15,832,679,554
- Put/Call ratio
- 61%
- Price per share
- $89.17
- Number of holders
- 431
- Value change
- +$224,283,938
- Number of buys
- 194
- Number of sells
- 185
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
11%
|
20,850,601
|
$1,940,565,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.5%
|
14,550,680
|
$1,354,231,000 | — | 30 Sep 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
6.4%
|
12,314,357
|
$1,146,097,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.2%
|
11,882,561
|
$1,105,909,000 | — | 30 Sep 2017 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
5%
|
9,638,644
|
$897,069,000 | — | 30 Sep 2017 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.2%
|
8,058,559
|
$750,010,000 | — | 30 Sep 2017 | |
| FMR LLC |
13F
|
Company |
4.2%
|
8,019,391
|
$746,365,000 | — | 30 Sep 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.1%
|
5,905,673
|
$549,641,000 | — | 30 Sep 2017 | |
| Invesco Ltd. |
13F
|
Company |
2.3%
|
4,489,391
|
$417,828,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
4,014,268
|
$373,623,000 | — | 30 Sep 2017 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.8%
|
3,472,712
|
$323,205,000 | — | 30 Sep 2017 | |
| Palo Alto Investors LP |
13F
|
Company |
1.3%
|
2,438,519
|
$226,953,000 | — | 30 Sep 2017 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.2%
|
2,381,774
|
$221,672,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
2,359,150
|
$219,566,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
2,207,554
|
$205,458,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.1%
|
2,146,708
|
$199,794,000 | — | 30 Sep 2017 | |
| MANNING & NAPIER ADVISORS LLC |
13F
|
Company |
1.1%
|
2,065,710
|
$192,254,000 | — | 30 Sep 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
2,009,051
|
$186,982,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.96%
|
1,844,893
|
$171,704,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.85%
|
1,643,436
|
$152,954,000 | — | 30 Sep 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.84%
|
1,630,004
|
$151,702,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.77%
|
1,480,724
|
$137,665,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
1,427,168
|
$132,753,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.72%
|
1,392,080
|
$129,555,000 | — | 30 Sep 2017 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.72%
|
1,390,890
|
$129,450,000 | — | 30 Sep 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.7%
|
1,348,373
|
$125,493,000 | — | 30 Sep 2017 | |
| Capital World Investors |
13F
|
Company |
0.64%
|
1,227,154
|
$114,211,000 | — | 30 Sep 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.59%
|
1,134,622
|
$105,599,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
1,104,080
|
$102,758,000 | — | 30 Sep 2017 | |
| USS Investment Management Ltd |
13F
|
Company |
0.56%
|
1,089,933
|
$101,440,000 | — | 30 Sep 2017 | |
| TCW GROUP INC |
13F
|
Company |
0.56%
|
1,072,969
|
$99,862,000 | — | 30 Sep 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.55%
|
1,061,612
|
$98,804,000 | — | 30 Sep 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.55%
|
1,058,751
|
$98,537,957 | — | 30 Sep 2017 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
1,020,239
|
$94,954,000 | — | 30 Sep 2017 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
990,261
|
$92,164,000 | — | 30 Sep 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.5%
|
970,764
|
$90,346,000 | — | 30 Sep 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.5%
|
967,654
|
$90,060,000 | — | 30 Sep 2017 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.47%
|
916,325
|
$85,282,000 | — | 30 Sep 2017 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.44%
|
855,047
|
$79,580,000 | — | 30 Sep 2017 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.41%
|
796,423
|
$74,123,000 | — | 30 Sep 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.4%
|
769,542
|
$71,621,000 | — | 30 Sep 2017 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.39%
|
756,546
|
$70,412,000 | — | 30 Sep 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.39%
|
749,150
|
$69,723,000 | — | 30 Sep 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.39%
|
743,900
|
$69,235,000 | — | 30 Sep 2017 | |
| NORGES BANK |
13F
|
Company |
0.38%
|
741,289
|
$68,992,000 | — | 30 Sep 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.37%
|
715,181
|
$66,562,000 | — | 30 Sep 2017 | |
| Senator Investment Group LP |
13F
|
Company |
0.36%
|
700,000
|
$65,149,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.35%
|
670,839
|
$62,435,000 | — | 30 Sep 2017 | |
| Swiss National Bank |
13F
|
Company |
0.33%
|
643,200
|
$59,863,000 | — | 30 Sep 2017 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.32%
|
614,862
|
$57,225,000 | — | 30 Sep 2017 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q4 2017
As of 31 Dec 2017,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
431 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
177,577,894 shares.
The largest 10 holders included
Capital Research Global Investors, Vanguard Group Inc, BlackRock Inc., JENNISON ASSOCIATES LLC, PRIMECAP MANAGEMENT CO/CA/, SANDS CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, FMR LLC, Invesco Ltd., and STATE STREET CORP.
This page lists
431
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
407
Q4 2017 holders
431
Holder diff
24
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.